JPMorgan Maintains Overweight Rating on GoodRx, PT Lowered to $5

Tuesday, Nov 11, 2025 11:16 am ET1min read
GDRX--

JPMorgan Maintains Overweight Rating on GoodRx, PT Lowered to $5

JPMorgan Maintains Overweight Rating on GoodRx, PT Lowered to $5

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments



Add a public comment...
No comments

No comments yet